Sergei Doulatov, Associate Professor, University of Washington, shared a post on X:
“Excited to share our latest work in Blood Cancer Discovery. We discover that SF3B1-mutated human HSCs are sensitized to CHK1 inhibitors due to pervasive mis-splicing of mitotic regulators. Led by Martina Sarchi, with Luca Malcovati and Robert K. Bradley.”
Read further.
Source: Sergei Doulatov/X